Faster Than the West? Rethinking Regulatory Pathways for Advanced Therapies

For years, regulation has been viewed as one of the biggest barriers to bringing advanced therapies to patients'slow approval timelines, rigid frameworks, and fragmented global pathways. But across several emerging markets, regulators are beginning to challenge this assumption. Driven by national innovation strategies and growing demand for faster patient access, countries in the Gulf and beyond are experimenting with more agile regulatory models'from parallel submission pathways and accelerated approvals to greater flexibility for rare and orphan therapies. This session explores how evolving regulatory frameworks are reshaping the global cell and gene therapy landscape. Hear from regulators, industry leaders, and policy experts as they discuss how adaptive regulation, international collaboration, and smarter approval pathways could accelerate global market entry, reduce time to patient access, and redefine where innovation reaches patients first."